Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 22, 2002
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusionC van Kesteren, R A Mathĵt, L López-Lázaro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2002
Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer modelMaria T Vlachaki, Andres Hernandez-Garcia, Michael Ittmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding studyC van Kesteren, E Cvitkovic, A Taamma, et al.
Psychopharmacology|May 29, 2017
Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individualsLuca Passamonti, M Luijten, H Ziauddeen, et al.
Brain : a Journal of Neurology|November 8, 2018
Early microglial activation and peripheral inflammation in dementia with Lewy bodiesAjenthan Surendranathan, Li Su, Elijah Mak, et al.
British Journal of Cancer|February 2, 2013
Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?L J L Forbes, A E Simon, F Warburton, et al.
BMJ Open|December 21, 2012
An international measure of awareness and beliefs about cancer: development and testing of the ABCAlice E Simon, Lindsay J L Forbes, David Boniface, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trialH Bonnefoi, S Litière, M Piccart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trialO Metzger Filho, F Cardoso, C Poncet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyH Bonnefoi, W Jacot, M Saghatchian, et al.
Pageof 11